Vaccinex plans Nasdaq exit as Alzheimer market pressure grows
Following equity shortcomings, Vaccinex ends its journey as a public company after six and a half…
Novo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations – TipRanks
Novo Nordisk (NVO) Sinks after Weight-Loss Drug Trial Misses Expectations TipRanks
38 attorneys general urge FDA to offer protection from fake weight loss drugs – Santa Clarita Valley Signal
38 attorneys general urge FDA to offer protection from fake weight loss drugs Santa Clarita Valley Signal
Reality star, 45, reveals 100lb weight loss thanks to Ozempic… see what she looks like now – Daily Mail
Reality star, 45, reveals 100lb weight loss thanks to Ozempic… see what she looks like now Daily…
Reality star, 45, reveals 100lb weight loss thanks to Ozempic… see what she looks like now – Daily Mail
Reality star, 45, reveals 100lb weight loss thanks to Ozempic… see what she looks like now Daily…
Eli Lilly’s first weight-loss pill could expand access to GLP-1s around the globe, executive says – Quartz
Eli Lilly’s first weight-loss pill could expand access to GLP-1s around the globe, executive says Quartz
New Molecule Competes with Ozempic, Showing Fewer Side Effects – DISCOVER Magazine
New Molecule Competes with Ozempic, Showing Fewer Side Effects DISCOVER Magazine
Novo Nordisk Shares Tumble 8% on CagriSema Weight Loss Miss – GuruFocus.com
Novo Nordisk Shares Tumble 8% on CagriSema Weight Loss Miss GuruFocus.com
Judge Denies Injunction for Copycats of Lilly’s Weight Loss Drug – Bloomberg Law
Judge Denies Injunction for Copycats of Lilly’s Weight Loss Drug Bloomberg Law
Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss – MedCity News
Novo Nordisk’s Next-Gen Obesity Drug Disappoints Again With Lower Than Expected Weight Loss MedCity News